Mumbai: Dentsu Creative India has won the digital creative mandate for two prominent healthcare brands - Shelcal and Unienzyme, which fall under the umbrella of Torrent Pharmaceuticals. The account was won following a multi-agency pitch and will be serviced from the agency’s Mumbai office.

As per the mandate, Dentsu Creative India will play a pivotal role in enhancing and expanding the digital presence of these brands by implementing a highly innovative and aggressive creative growth strategy. This partnership marks an exciting milestone for these brands as they make their debut in the OTC (Over-the-Counter) market, presenting a significant opportunity to establish their presence and reach a broader audience.

The collaboration between the agency and the brands goes beyond conventional approaches. The aim is to delve into lesser-known health topics in India, particularly focusing on calcium deficiency and gut health. The shared objective is to develop effective communication and educational campaigns that not only attract new customers but also cultivate stronger brand loyalty among existing ones.

Dentsu Creative India president- digital experience Sahil Shah said, “With Torrent Pharmaceuticals venturing into the OTC segment with significant plans, we felt it was the right time to partner up and address their digital creative activations. Together, we have embarked on a journey to revolutionize their digital marketing in this 'waiting to innovate' OTC healthcare domain. I am grateful for their trust in Dentsu Creative and confident that we will blend innovation and creativity to craft messages that truly resonate, fostering meaningful connections with audiences."

Dentsu Creative India managing partner Manika Juneja added, “Torrent Pharma’s digital creative mandate is a step forward in strengthening Dentsu Creative's portfolio within the pharmaceutical category of brands. We are thrilled about this new victory and look forward to a stronger and fruitful partnership with lots of exciting work inspired by Modern Creativity in the near future.”